MedPath

To evaluate the safety & efficacy of Fungiwin Cream in patients with superficialfungal infections

Phase 4
Conditions
Health Condition 1: B369- Superficial mycosis, unspecified
Registration Number
CTRI/2023/07/054620
Lead Sponsor
SKM Siddha and Ayurveda Company India Private Limited
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Closed to Recruitment of Participants
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1 Male female patients aged = 18 years and =65 years at the time of consent

2 Patients who are recently diagnosed for dermal fungal infection and treatment naive

3 Patients who are willing to give voluntary written informed

consent

Exclusion Criteria

1. Patients with allergies to cosmetics, moisturizers, and whitening/bleaching agents.

2. Patients who have sunburn, chapped, or irritated skin or open wounds;

3. Patients with history of skin cancer or treatment for any type of cancer and use of immunosuppressive medication within past 2 years;

4.Patients with terminally ill and any other condition in the opinion of the investigator which would affect the safety of the patient

5 Patients who are not willing to discontinue any other personal care products containing whitening bleaching properties during the study period

6 Female patients who are breast feeding pregnant or intends to become pregnant during the study

Study & Design

Study Type
PMS
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath